Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma

被引:50
作者
Remaud, G
Boisdron-Celle, M
Morel, A
Gamelin, A
机构
[1] INSERM, U564, Anticanc Ctr Paul Papin, F-49933 Angers, France
[2] INSERM, Dept Med Oncol, U564, Anticanc Ctr Paul Papin, Angers, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 824卷 / 1-2期
关键词
tegafur; UFT; S1; 5-fluorouracil; 5-fluorodihydrouracil; LC/MS-MS;
D O I
10.1016/j.jchromb.2005.07.023
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Ftorafur (FT), an oral prodrug of 5-FU, is part of UFT and S1, two oral prodrugs widely used in digestive tract cancer. We set up a liquid chromatography tandem mass spectrometry (LC/MS-MS) method, chosen for its specificity of detection, for simultaneously measuring in human plasma FT, 5-FU and 5-FUH2. Separation was performed on a Hypercarb column. Linearity, precision and accuracy were validated in the concentration range studied for each compound. This simple and reliable LC/MS-MS method allows specific, sensitive and reproducible quantification of Fr, 5-FU and FUH2 in human plasma and can be applied to further pharmacokinetic studies in patients treated with FT-based prodrugs. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:153 / 160
页数:8
相关论文
共 24 条
[1]   Sensitive liquid chromatographic assay for the simultaneous determination of 5-fluorouracil and its prodrug, tegafur, in beagle dog plasma [J].
Chu, DF ;
Gu, JK ;
Liu, WH ;
Fawcett, JP ;
Dong, QG .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 795 (02) :377-382
[2]   A novel mutant allele of the CYP2A6 gene (CYP2A6*11) found in a cancer patient who showed poor metabolic phenotype towards tegafur [J].
Daigo, S ;
Takahashi, Y ;
Fujieda, M ;
Ariyoshi, N ;
Yamazaki, H ;
Koizumi, W ;
Tanabe, S ;
Saigenji, K ;
Nagayama, S ;
Ikeda, K ;
Nishioka, Y ;
Kamataki, T .
PHARMACOGENETICS, 2002, 12 (04) :299-306
[3]  
ELSAYED YM, 1983, CANCER RES, V43, P4039
[4]   METABOLIC-ACTIVATION OF FTORAFUR [R,S-1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL] - THE MICROSOMAL OXIDATIVE PATHWAY [J].
ELSAYED, YM ;
SADEE, W .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (18) :3006-3008
[5]   POPULATION STUDY OF DIHYDROPYRIMIDINE DEHYDROGENASE IN CANCER-PATIENTS [J].
ETIENNE, MC ;
LAGRANGE, JL ;
DASSONVILLE, O ;
FLEMING, R ;
THYSS, A ;
RENEE, N ;
SCHNEIDER, M ;
DEMARD, F ;
MILANO, G .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) :2248-2253
[6]  
FLEMING RA, 1993, EUR J CANCER, V29A, P740
[7]   A simple chromatographic method for the analysis of pyrimidines and their dihydrogenated metabolites [J].
Gamelin, E ;
BoisdronCelle, M ;
Larra, F ;
Robert, J .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 1997, 20 (19) :3155-3172
[8]   GLC DETERMINATION FOR FTORAFUR IN BIOLOGICAL-FLUIDS [J].
HILLS, EB ;
GODEFROI, VC ;
OLEARY, IA ;
BURKE, M ;
ANDRZEJEWSKI, D ;
BRUKWINSKI, W ;
HORWITZ, JP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (10) :1497-1499
[9]   FLUORESCENCE DETERMINATION OF 5-FLUOROURACIL AND 1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL IN BLOOD-SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
IWAMOTO, M ;
YOSHIDA, S ;
HIROSE, S .
JOURNAL OF CHROMATOGRAPHY, 1984, 310 (01) :151-157
[10]   High-performance liquid chromatographic determination of 5-fluorouracil and its prodrugs, tegafur and 4-deoxy-5-fluorouracil, in rat plasma [J].
Jarugula, VR ;
Boudinot, FD .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 677 (01) :199-203